OncoCyte Share Holder Equity 2014-2025 | IMDX
OncoCyte share holder equity from 2014 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
OncoCyte Annual Share Holder Equity
(Millions of US $) |
| 2024 |
$-12 |
| 2023 |
$20 |
| 2022 |
$34 |
| 2021 |
$65 |
| 2020 |
$33 |
| 2019 |
$31 |
| 2018 |
$3 |
| 2017 |
$4 |
| 2016 |
$10 |
| 2015 |
$10 |
| 2014 |
$-1 |
| 2013 |
$4 |
OncoCyte Quarterly Share Holder Equity
(Millions of US $) |
| 2025-03-31 |
$10 |
| 2024-12-31 |
$-12 |
| 2024-09-30 |
$10 |
| 2024-06-30 |
$23 |
| 2024-03-31 |
$12 |
| 2023-12-31 |
$20 |
| 2023-09-30 |
$38 |
| 2023-06-30 |
$44 |
| 2023-03-31 |
$38 |
| 2022-12-31 |
$34 |
| 2022-09-30 |
$77 |
| 2022-06-30 |
$83 |
| 2022-03-31 |
$57 |
| 2021-12-31 |
$65 |
| 2021-09-30 |
$99 |
| 2021-06-30 |
$103 |
| 2021-03-31 |
$107 |
| 2020-12-31 |
$33 |
| 2020-09-30 |
$35 |
| 2020-06-30 |
$40 |
| 2020-03-31 |
$37 |
| 2019-12-31 |
$31 |
| 2019-09-30 |
$29 |
| 2019-06-30 |
$34 |
| 2019-03-31 |
$38 |
| 2018-12-31 |
$3 |
| 2018-09-30 |
$8 |
| 2018-06-30 |
$7 |
| 2018-03-31 |
$9 |
| 2017-12-31 |
$4 |
| 2017-09-30 |
$8 |
| 2017-06-30 |
$6 |
| 2017-03-31 |
$9 |
| 2016-12-31 |
$10 |
| 2016-09-30 |
$13 |
| 2016-06-30 |
$4 |
| 2016-03-31 |
$7 |
| 2015-12-31 |
$10 |
| 2015-09-30 |
$0 |
| 2015-06-30 |
$0 |
| 2015-03-31 |
$0 |
| 2014-12-31 |
$-1 |
| 2013-12-31 |
$4 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Services |
$0.090B |
$0.002B |
|
OncoCyte Corporation is primarily focused on the development of novel, non-invasive blood and urine diagnostic tests for detection of cancer. OncoCyte Corporation is based in Alameda, California.
|
